Skip to main content
Fig. 1 | Clinical Sarcoma Research

Fig. 1

From: A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis

Fig. 1

Genomic landscape of bone and soft tissue sarcoma. a Average frequency per patient of SNVs, amplifications, deletions, and fusions per cancer type for 1291 Stanford patients with tumor sequencing. When ordered by average number of SNVs, bone and soft tissue have the lowest amount of SNVs while having the highest relative proportion of copy number and structural rearrangements. b Oncoprint [30] plot of genomic alterations in soft tissue sarcoma clustered by frequency. The genes are ordered from most frequent (top) to least frequent (bottom). Tumor histology is shown on the topmost colored bar

Back to article page